Jeffrey Berinstein
Assistant Professor of Internal Medicine
Department of Internal Medicine, Division of Gastroenterology and Hepatology
1500 E. Medical Center Dr.
Ann Arbor, MI
[email protected]

Available to mentor
Jeffrey Berinstein
Assistant Professor
  • About
  • Qualifications
  • Center Memberships
  • Research Overview
  • Recent Publications
    • About

    I am interested in caring for patients with Inflammatory Bowel Disease. Specifically, I am interested in hospitalization patients with severe inflammatory bowel disease and improving access to high costs specialty medications.

    Qualifications
    • Clinical Trials Academy
      University of Michigan, Ann Arbor, 2022
    • Fellow
      University of Michigan–Ann Arbor, Gastroenterology and Hepatology, 2021
    • Chief Resident University of Michigan Health System, Ann Arbor, Michigan
      University of Michigan Health System, Internal Medicine- Gastroenterology, 2021
    • Resident
      University of Michigan, Internal Medicine, 2018
    • MS
      University of Michigan–Ann Arbor, Ann Arbor, 2019
    • MD
      Technion – Israel Institute of Technology, Haifa, 2015
    • BSc
      McMaster University, Hamilton, 2010
    Center Memberships
    • Center Member
      Institute for Healthcare Policy and Innovation
    Research Overview

    I am interested in employing novel research methods to optimizing care delivery for patients with inflammatory bowel disease. I specifically interested in using novel machine learning, adaptive intervention, and trial design methodology to building evidence-based patient-tailored treatment pathways for patients admitted to the hospital with acute severe ulcerative colitis.

    Recent Publications See All Publications
    • Journal Article
      Morning light treatment for inflammatory bowel disease: a clinical trial.
      Cohen-Mekelburg S, Goldstein CA, Rizvydeen M, Fayyaz Z, Patel PJ, Berinstein JA, Bishu S, Cushing-Damm KC, Kim HM, Burgess HJ. BMC Gastroenterol, 2024 May 22; 24 (1): 179 DOI:10.1186/s12876-024-03263-2
      PMID: 38778264
    • Journal Article
      Crohn's Disease Associated With IgA Nephropathy Effectively Treated With the Interleukin-23 Inhibitor Risankizumab
      Larson C, Munir N, Rao P, Farkash E, Kathuria P, Romain D, Berinstein J. ACG Case Reports Journal, 11 (7): e01437 - e01437. DOI:10.14309/crj.0000000000001437
    • Journal Article
      Effectiveness of Upadacitinib for Patients With Acute Severe Ulcerative Colitis: A Multicenter Experience.
      Berinstein JA, Karl T, Patel A, Dolinger M, Barrett TA, Ahmed W, Click B, Steiner CA, Dulaney D, Levine J, Hassan SA, Perry C, Flomenhoft D, Ungaro RC, Berinstein EM, Sheehan J, Cohen-Mekelburg S, Regal RE, Stidham RW, Bishu S, Colombel J-F, Higgins PDR. Am J Gastroenterol, 2024 Mar 27; DOI:10.14309/ajg.0000000000002674
      PMID: 38275248
    • Journal Article
      Timing Is Everything: The Lifesaving Potential of Early Medical Therapy in Acute Severe Ulcerative Colitis.
      Kathuria P, Higgins PDR, Berinstein JA. Am J Gastroenterol, 2024 Jun 12; DOI:10.14309/ajg.0000000000002867
      PMID: 38864521
    • Journal Article
      Legalization of Cannabis Does Not Reduce Opioid Prescribing in Patients With Inflammatory Bowel Disease: A Difference-in-Difference Analysis.
      Noureldin M, Van T, Cohen-Mekelburg S, Scott FI, Higgins PDR, Stidham RW, Hou J, Waljee AK, Berinstein JA. Am J Gastroenterol, 2024 May 21; DOI:10.14309/ajg.0000000000002834
      PMID: 38767951
    • Journal Article
      Racial Disparity in Esophageal Squamous Cell Carcinoma Treatment and Survival in the United States.
      Noureldin M, Rubenstein JH, Urias E, Berinstein JA, Cohen-Mekelburg S, Saini SD, Higgins PD, Waljee AK. Am J Gastroenterol, 2024 May 1; 119 (5): 830 - 836. DOI:10.14309/ajg.0000000000002606
      PMID: 37975573
    • Journal Article
      Sa1744 INTRAOPERATIVE AND POSTOPERATIVE OUTCOMES IN TOFACITINIBTREATED ACUTE SEVERE ULCERATIVE COLITIS PATIENTS UNDERGOING TOTAL ABDOMINAL COLECTOMY
      Larson C, Berinstein J, Romain D, Tedesco NR, Kathuria P, Seidelin JB, Ovesen PD, Uzzan M, Constant BD, El-Hussuna A, Higgins PD, Steenholdt C. Gastroenterology, 2024 May; 166 (5): s-502-s-503 DOI:10.1016/s0016-5085(24)01629-9
    • Journal Article
      Sa1792 C-REACTIVE PROTEIN IS A BETTER PREDICTOR OF 90-DAY COLECTOMY THAN CALCULATED BASELINE INFLIXIMAB CLEARANCE IN ACUTE SEVERE ULCERATIVE COLITIS
      Aintabi D, Kathuria P, Romain D, Larson C, Tedesco NR, Cohen-Mekelburg S, Higgins PD, Berinstein J. Gastroenterology, 2024 May; 166 (5): s - 525. DOI:10.1016/s0016-5085(24)01677-9